Overview
Amal Farag is a primary care provider, practicing in Internal Medicine in Brooklyn, New York.
Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis (NASH).
She is actively involved in clinical research, co-authoring 1 peer reviewed article.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- POS
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
800 Poly Pl, Brooklyn, NY 11209
Additional Areas of Focus
Dr. Farag has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Vivian & Seymour Milstein Family Heart Center
Mathew S. Maurer, MD - Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus. He is the Director of the Cardiac Amyloidosis Program. He has published over 300 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults. Dr. Maurer is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Maurer is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure And Transplant Cardiology. Dr. Maurer is currently accepting new patients.
Center For Community Health At NewYork-Presbyterian Brooklyn Methodist Hospital
Peter Martin is an Internal Medicine provider practicing medicine in Brooklyn, New York. Dr. Martin is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Martin is currently accepting new patients.
NewYork Presbyterian Columbia University Irving Medical Center
John Bilezikian is an Internal Medicine provider practicing medicine in New York, New York. Dr. Bilezikian is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Hypoparathyroidism, Hypercalcemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Amal Farag
How do I make an appointment with Dr. Amal Farag?
You can book an appointment with Dr. Amal Farag by calling their office at 718-630-2808. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
What conditions does Dr. Amal Farag specialize in?
While Dr. Amal Farag is a Internal Medicine, they have specific expertise in Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Amal Farag participate in research or clinical trials?
Yes. Dr. Amal Farag has published 1 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Dr. Amal Farag's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Amal Farag accept my insurance?
Dr. Amal Farag accepts most major insurance plans, including Aetna and EmblemHealth. We recommend calling the office directly at 718-630-2808 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers